BioStem Technologies, Inc. (BSEM) Misses Q2 EPS by 131c

BioStem Technologies, Inc. (OTC: BSEM) reported Q2 EPS of ($0.03), $1.31 worse than the analyst estimate of $1.28. Revenue for the quarter came in at $49.29 million versus the consensus estimate of $102.3 million.

For earnings history and earnings-related data on BioStem Technologies, Inc. (BSEM) click here.

You May Also Be Interested In

• Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
• USCB Financial Holdings, Inc. (USCB) Reports In-Line Q2 EPS
• Columbia Banking System (COLB) Tops Q2 EPS by 3c